Evidence map›Paper›PMID 26154658›Full record

ArticleInternational journal of environmental research and public health2015

The AhR Ligand, TCDD, Regulates Androgen Receptor Activity Differently in Androgen-Sensitive versus Castration-Resistant Human Prostate Cancer Cells.

Maryam Ghotbaddini, Joann B Powell

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Veterinary medicine international · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Maryam GhotbaddiniDepartment of Biological Sciences, Clark Atlanta University, 223 James P. Brawley Drive, S.W. Atlanta, GA 30314, USA. maryam.ghotbaddini@students.cau.edu.
Joann B PowellDepartment of Biological Sciences, Clark Atlanta University, 223 James P. Brawley Drive, S.W. Atlanta, GA 30314, USA. jpowell@cau.edu.
Atlanta University Center · USClark Atlanta University · US

Funding

The Hampton University regional Transdisciplinary Collaborative CenterU54MD008621 · NIMHD · HAMPTON UNIVERSITY · PI SAMUEL, RAYMOND E · 2013 to 2017
$13.5M
Technologies/Resources for Core LaboratoriesG12MD007590 · NIMHD · CLARK ATLANTA UNIVERSITY · PI KHAN, SHAFIQ A · 2012 to 2018
$7.6M
NIMHD NIH HHS 8 G12 MD007590NIMHD NIH HHS G12 MD007590NIMHD NIH HHS U54 MD008621NIMHD NIH HHS U54MD008621-01
6 · The paper itself

Abstract

The reported biological effects of TCDD include induction of drug metabolizing enzymes, wasting syndrome and tumor promotion. TCDD elicits most of its effects through binding the aryl hydrocarbon receptor (AhR). TCDD induced degradation of AhR has been widely reported and requires ubiquitination of the protein. The rapid depletion of AhR following TCDD activation serves as a mechanism to modulate AhR mediated gene induction. In addition to inducing AhR degradation, TCDD has been reported to induce degradation of hormone receptors. The studies reported here, evaluate the effect of TCDD exposure on androgen receptor (AR) expression and activity in androgen-sensitive LNCaP and castration-resistant C4-2 prostate cancer cells. Our results show that TCDD exposure does not induce AhR or AR degradation in C4-2 cells. However, both AhR and AR are degraded in LNCaP cells following TCDD exposure. In addition, TCDD enhances AR phosphorylation and induces expression of AR responsive genes in LNCaP cells. Our data reveals that TCDD effect on AR expression and activity differs in androgen-sensitive and castration-resistant prostate cancer cell models.

Indexed as

CastrationProstatic NeoplasmsCell Line, TumorCytochrome P-450 CYP1A1HumansLigandsMalePolychlorinated DibenzodioxinsReceptors, AndrogenReceptors, Aryl HydrocarbonSignal TransductionTranscription, GeneticAR protein, humanCytochrome P-450 CYP1A1LigandsPolychlorinated DibenzodioxinsReceptors, AndrogenReceptors, Aryl HydrocarbonAhRandrogen receptorcastration-resistantprostate cancerTCDD/dioxin

Identifiers

PMID26154658
PMCPMC4515671
OpenAlexW1571335319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.